SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001493152-21-030883
Filing Date
2021-12-08
Accepted
2021-12-08 21:58:31
Documents
1
Period of Report
2021-11-29

Document Format Files

Seq Description Document Type Size
1 ownership.html 3  
1 ownership.xml 3 1535
  Complete submission text file 0001493152-21-030883.txt   2957
Mailing Address 3 COLUMBUS CIRCLE 15TH FLOOR NEW YORK NY 10019
Business Address 3 COLUMBUS CIRCLE 15TH FLOOR NEW YORK NY 10019 347-480-9760
Indaptus Therapeutics, Inc. (Issuer) CIK: 0001857044 (see all company filings)

IRS No.: 863158720 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 13731 NORTHWOOD RD., NW SEATTLE WA 98177
Business Address
Gilbert Mark John (Reporting) CIK: 0001897698 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-40652 | Film No.: 211480164